1. The novel GLP‐1‐gastrin dual agonist, ZP3022, increases β‐cell mass and prevents diabetes in db/db mice. Issue 1 (9th September 2012) Authors: Fosgerau, K.; Jessen, L.; Lind Tolborg, J.; Østerlund, T.; Schæffer Larsen, K.; Rolsted, K.; Brorson, M.; Jelsing, J.; Skovlund Ryge Neerup, T. Journal: Diabetes, obesity & metabolism Issue: Volume 15:Issue 1(2013:Jan.) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗